Filing Flows › Milestone Scientific (MLSS) › Q1 2025
Milestone Scientific (MLSS) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 15, 2025
Milestone Scientific (MLSS) reported revenue of $2.2M for the first quarter 2025 (Q1 2025), -0.7% from a year earlier and +11% from the quarter before. Operating margin was -89.5%, net loss $2.0M (89.3% of revenue).
Milestone Scientific, Q1 2025: revenue $2.2M (-0.7% year over year), operating margin -89.5%, net loss $2.0M, operating cash flow −$1.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.2M | +11% | -0.7% |
| Operating profit | −$2.0M | — | — |
| Net earnings | −$2.0M | — | — |
| Operating cash flow | −$1.0M | — | — |
What changed
Revenue was $2.2M in Q1 2025, down 1% year over year and up 11% from the previous quarter.
Gross margin was 73.8%, down 0.7 points from a year earlier. Operating costs exceeded revenue by $2.0M, an operating margin of -89.5%. Operating expenses grew 16% against a revenue fall of 1%. The fastest-growing cost line was Research & development (+292%). The quarter ended with a net loss of $2.0M, narrower than the previous quarter's $2.0M loss.
Operating cash flow was −$1.0M. Non-cash charges added back $19K of depreciation and amortization and $331K of share-based compensation. Working capital and other items added $636K. Capital expenditures of $1K exceeded it, leaving free cash flow of −$1.0M.
Questions
What was Milestone Scientific's revenue in the first quarter 2025?
Milestone Scientific (MLSS) reported revenue of $2.2M for the first quarter 2025 (Q1 2025), -0.7% from a year earlier and +11% from the quarter before.
Was Milestone Scientific profitable in the first quarter 2025?
Operating loss was $2.0M (-89.5% of revenue) and net loss $2.0M.